638.09 USD
+5.53 (+0.87%)
Last: Feb 4, 2026, 10:34 AM
ChartMill assigns a Buy % Consensus number of 81% to IDXX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 781.34. This target is 22.45% above the current price.
- IDXX was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about IDXX.
- In the previous month the buy percentage consensus was at a similar level.
- IDXX was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-03 | BTIG | Maintains | Buy -> Buy |
| 2026-02-03 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-04 | BTIG | Maintains | Buy -> Buy |
| 2025-11-04 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-31 | Stifel | Upgrade | Hold -> Buy |
| 2025-10-01 | UBS | Initiate | Neutral |
| 2025-08-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-17 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-07-02 | Stifel | Maintains | Hold -> Hold |
| 2025-06-11 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-05-19 | Stifel | Maintains | Hold -> Hold |
| 2025-05-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-14 | Stifel | Maintains | Hold -> Hold |
| 2025-02-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-04 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-01-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-02 | Leerink Partners | Initiate | Outperform |
| 2024-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-04 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-10 | Stifel | Maintains | Hold -> Hold |
| 2024-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-07-25 | BTIG | Initiate | Buy |
| 2024-06-24 | Stifel | Maintains | Hold -> Hold |
IDEXX LABORATORIES INC / IDXX FAQ
What is the average price target for IDEXX LABORATORIES INC (IDXX) stock?
22 analysts have analysed IDXX and the average price target is 781.34 USD. This implies a price increase of 22.45% is expected in the next year compared to the current price of 638.09.
What is the consensus rating for IDXX stock?
The consensus rating for IDEXX LABORATORIES INC (IDXX) is 80.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for IDXX stock?
The number of analysts covering IDEXX LABORATORIES INC (IDXX) is 22.